Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jaroslava Voglova"'
Autor:
Lukas Semerad, Daniela Žáčková, Petra Belohlavkova, Jaroslava Voglova, Pavel Žák, Edgar Faber, Tomas Papajik, Ivana Skoumalova, Michal Karas, Pavel Jindra, Hana Klamová, Cyril Salek, Dana Srbová, Hana Zizkova, Lukas Stejskal, Olga Cerna, Eduard Cmunt, Petra Cicatkova, Anezka Kvetkova, Tomas Hornak, Ivana Jeziskova, Tomas Jurcek, Barbora Weinbergerová, Jirina Prochazkova, Katerina Machova Polakova, Adam Svobodnik, Radka Stepanova, Jiri Mayer
Publikováno v:
HemaSphere, Vol 7, p e70530bf (2023)
Externí odkaz:
https://doaj.org/article/e7c94ed4ac6546329523a51b5039e6a2
Autor:
Petra Belohlavkova, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova, Katerina Hrochova, Jana Malakova, Jiri Mayer, Pavel Zak
Publikováno v:
Archives of Medical Science, Vol 14, Iss 6, Pp 1416-1423 (2018)
Externí odkaz:
https://doaj.org/article/602ee88bf1304c86809033b0d80e72f9
Autor:
Stein-Erik Gullaksen, Jørn Skavland, Sonia Gavasso, Vinko Tosevski, Krzysztof Warzocha, Claudia Dumrese, Augustin Ferrant, Tobias Gedde-Dahl, Andrzej Hellmann, Jeroen Janssen, Boris Labar, Alois Lang, Waleed Majeed, Georgi Mihaylov, Jesper Stentoft, Leif Stenke, Josef Thaler, Noortje Thielen, Gregor Verhoef, Jaroslava Voglova, Gert Ossenkoppele, Andreas Hochhaus, Henrik Hjorth-Hansen, Satu Mustjoki, Sieghart Sopper, Francis Giles, Kimmo Porkka, Dominik Wolf, Bjørn Tore Gjertsen
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
Monitoring of single cell signal transduction in leukemic cellular subsets has been proposed to provide deeper understanding of disease biology and prognosis, but has so far not been tested in a clinical trial of targeted therapy. We developed a comp
Externí odkaz:
https://doaj.org/article/e5220aa38eb9478f96396fc7b61232c4
Autor:
Cornelia Zeidler, Ulrike A.H. Grote, Anna Nickel, Beate Brand, Göran Carlsson, Emília Cortesão, Carlo Dufour, Caroline Duhem, Gundula Notheis, Helen A. Papadaki, Hannah Tamary, Geir E. Tjønnfjord, Fabio Tucci, Jan Van Droogenbroeck, Christiane Vermylen, Jaroslava Voglova, Blanca Xicoy, Karl Welte
Publikováno v:
Haematologica, Vol 99, Iss 8 (2014)
Long-term granulocyte-colony stimulating factor treatment has been shown to be safe and effective in severe chronic neutropenia patients. However, data on its use during pregnancy are limited. To address this issue, we analyzed all pregnancies report
Externí odkaz:
https://doaj.org/article/2c0fa1de741d42b896bfbff020a8377d
Autor:
Zdenek, Racil, Eva, Koritakova, Tomasz, Sacha, Hana, Klamova, Petra, Belohlavkova, Edgar, Faber, Delphine, Rea, Ludmila, Malaskova, Jirina, Prochazkova, Daniela, Zackova, Jaroslava, Voglova, Joanna, Wącław, Petr, Cetkovsky, Pavel, Zak, Jiri, Mayer
Publikováno v:
American journal of hematology. 93(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ea8814c94e8bb752b5f2180b7359f05
https://pubmed.ncbi.nlm.nih.gov/30054949
https://pubmed.ncbi.nlm.nih.gov/30054949
Autor:
Zdenek, Racil, Filip, Razga, Hana, Klamova, Jaroslava, Voglova, Petra, Belohlavkova, Ludmila, Malaskova, David, Potesil, Jan, Muzik, Daniela, Zackova, Katerina Machova, Polakova, Zbynek, Zdrahal, Jana, Malakova, Jiri, Suttnar, Jan, Dyr, Jiri, Mayer
Publikováno v:
Hematological oncology. 32(2)
This multicentre study focused on monitoring imatinib mesylate (IMA) trough plasma (Ctrough ) and intracellular (IMA Cintrac ) concentrations in 228 chronic myelogenous leukaemia patients. The median of measured IMA Ctrough in our patient group was 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ad0486c4be6038ca5a044dad5cd1ce1
https://pubmed.ncbi.nlm.nih.gov/23963760
https://pubmed.ncbi.nlm.nih.gov/23963760
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
Publikováno v:
Acta Medica, Vol 59, Iss 2, Pp 50-53 (2016)
Background: A combination of low-dose thalidomide and corticosteroids is a treatment option for anaemic patients with primary myelofibrosis (PMF) who are not eligible for allogeneic hematopoietic stem cell transplantation. Methods: We describe the ou
Externí odkaz:
https://doaj.org/article/b85dc71fb2934dd19688ce05d2d099b4
Autor:
Hana Klamová, Kateřina Machová Poláková, Jan Mužík, Zdeněk Ráčil, Daniela Žáčková, Kateřina Steinerová, Michal Karas, Edgar Faber, Eva Demečková, Zuzana Michalovičová‐Sninská, Jaroslava Voglová, Ľudmila Demitrovičová, Eva Mikušková, Elena Tóthová, Juraj Chudej, Imrich Markuljak, Eduard Cmunt, Jana Moravcová, Dana Dvořáková, Kyra Michalová, Marie Jarošová, Markéta Marková Šťastná, Petr Cetkovský, Ladislav DuŠek, Vladimír Koza, Marek Trněný, Karel Indrák
Publikováno v:
Cancer Medicine, Vol 2, Iss 2, Pp 216-225 (2013)
Abstract We evaluated responses to the treatment and long‐term outcomes of chronic myeloid leukemia patients treated with imatinib as first‐line treatment in routine clinical setting from two countries with centralized tyrosine kinase inhibitors
Externí odkaz:
https://doaj.org/article/3352c3f69ea544aab068556ac3c96068
Autor:
Karolína Jankovičová, Jan Krejsek, Otakar Kopecký, Jaroslava Voglová, Zuzana Škrabková, Jakub Novosad
Publikováno v:
Acta Medica, Vol 47, Iss 3, Pp 181-185 (2004)
The apoptosis failure in cytostatic treatment of haemoblastosis is one of the means of chemoresistance. We were interested in the relationship of the after-doxorubicin-treatment-AML cells apoptosis and the immunophenotype, selected clinical and labor
Externí odkaz:
https://doaj.org/article/8556732ff0ef4d06a4b2707b4dddbcda